Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067077 · ClinicalTrials.gov registry record · NA
A Prospective, Contralateral, Eye to Eye Comparison of SMILE Surgery to LASIK Surgery
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03067077: Completed NA study, sponsored by Stanford University.
NCT03067077 is a NA study that has completed, run by Stanford University. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03067077, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Subjects will undergo SMILE surgery in one eye and LASIK surgery in their other eye to correct myopia.
Primary Outcome
ETDRS testing lane
Interventions
- PROCEDURE LASIK
- PROCEDURE SMILE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2017-03-12 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
What the finished NCT03067077 record still lists
NCT03067077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which LASIK is the first listed.
NCT03067077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03067077 about?
NCT03067077 is a clinical study titled "A Prospective, Contralateral, Eye to Eye Comparison of SMILE Surgery to LASIK Surgery". Subjects will undergo SMILE surgery in one eye and LASIK surgery in their other eye to correct myopia.
What is the current status of trial NCT03067077?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2017-03-12. Estimated completion is 2021-03-15.
What interventions are being tested in trial NCT03067077?
The interventions under investigation include: LASIK (PROCEDURE), SMILE (PROCEDURE).
Who is sponsoring clinical trial NCT03067077?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03067077's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI